从武汉东湖高新区科创局获悉，该区出台《关于支持脑机接口产业创新发展的若干措施》，在国内率先 为脑机接口产业引道铺路。这一政策围绕技术攻关、成果应用、创新主体和产业生态等五大方面，精准 推出11条具体举措。此次出台的"脑机接口11条"政策，支持力度大、覆盖范围广、针对性强。对重大脑 机接口产品研发，按研发费用最高30%给予支持，额度最高不超过5000万元。支持建设国际脑机接口创 新中心，认定后每年最高给予1000万元运营资金。同时，大力引育海内外高层次人才，经认定的创业人 才最高可获1000万元持续资金支持。 ...

8月，湖北脑机接口产业创新发展联盟在光谷成立。目前，东湖高新区正推进建设光谷脑机接口产业集 聚区，其创新驱动核——国际脑机接口创新中心，由东湖高新区联合同济医院、协和医院等单位建设， 将构建从概念验证、临床试验、注册检验到产业转化的全链条服务体系。(完) 据了解，为推进脑机接口产业建设，光谷明确"五个一"实施路径，即成立一个产业联盟、建设一个特色 园区、出台一项专项政策、发布一批应用场景、设立一支产业基金。 《措施》围绕加强技术产品攻关、推动技术成果应用、壮大创新主体、构建产业创新生态等方面，推出 系列政策举措。其中，在技术产品攻关方面，支持脑机接口领域企业联合高校院所、医疗机构，在运动 控制、言语合成、神经疾病治疗、视觉重建等方面研发重大脑机接口产品，同时支持脑机接口医疗器械 研发；在技术成果应用方面，支持建设脑机接口试验服务平台、脑机接口试验设备共享平台，支持脑机 接口产品首试首用。 为壮大脑机接口产业创新主体，《措施》提出，支持打造脑机接口创新中心，给予每年最高1000万元运 营资金支持；鼓励脑机接口企业联合湖北实验室、光电子领域龙头企业组建产业联合共同体，推动在医 疗领域、康养领域和工业安全领域示范应 ...

在百卅岁月里，天津大学始终以"兴学强国"为魂，用"实事求是"的精神滋养着一代又一代学子。如今， 在资本市场的IPO赛道上，"天大系"正以一种低调却坚定的姿态崭露头角——从人工智能到智能制造， 从工业软件到大数据服务，多位天大校友掌舵的企业正排队叩响上市大门，用硬科技实力书写属于天大 人的资本故事。 十月的海河，波光粼粼映着秋阳；卫津路的梧桐叶，沙沙翻涌着岁月的故事。 10月2日，这座承载着中国近代高等教育荣光的学府——天津大学，迎来了130周年华诞。从1895年盛宣 怀奏设北洋大学堂算起，这座"中国第一所现代大学"始终以"兴学强国"为魂，在烽火中播撒科学火种， 在建设中输送建设栋梁，用"实事求是"的精神刻写下与国同行的壮阔史诗。 若论从这里走出的商业巨擘，天大或许不如某些高校声名显赫。校园里鲜少流传"校友首富"的传奇，财 经版也难见"天大系资本"的高频曝光。但鲜有人知的是，这座低调的学府正以另一种方式深度参与时代 变革：当"科技成果转化"成为国家战略关键词，当"硬科技创业"成为经济增长新引擎，天大正悄然在创 投领域织就一张服务创新的网络，成为高校推动科技与产业深度融合的重要力量。 2024年，这份"低调的进取 ...

■新华社记者邬焕庆、魏一骏、顾小立 数联全球，商通天下。9月25日至29日，第四届全球数字贸易博览会在浙江杭州举办。聚焦"在数 贸会看见创新未来"的年度主题，154个国家和地区设展或参会，带来数字贸易领域最新成果。 2023年，习近平主席向第二届全球数字贸易博览会致贺信，希望各方充分利用全球数字贸易博览 会平台，共商合作、共促发展、共享成果，携手将数字贸易打造成为共同发展的新引擎，为世界 经济增长注入新动能。 四届数贸会，展览面积、线下展商、专业客商等数据屡创新高，展会影响力不断提升。 来自全球的客商深入洽谈、新技术新产品首发首秀、一批重大项目签约落地……本届数贸会的会 场内外，一幕幕生动场景，勾勒出全球数字贸易蓬勃发展的新图景。 平台集聚效应日益彰显 从机组智能排班到飞机健康管理，从航空安全智能中枢到发动机精益管理系统……本届数贸会， 长龙航空带来人工智能在提升航班运行效率、保障飞行安全、降低运营成本等方面的最新成果， 并向行业领域开放合作。 打造发展新引擎 共享合作新未来 ——从第四届数贸会看数字贸易发展新气象 "这已经是长龙航空连续第4年参加数贸会，希望利用这个平台结识更多领域的合作伙伴，同时也 希望在 ...

Summary of Medical Device and Healthcare Services Industry Conference Call Industry Overview - The medical device sector is experiencing improved growth rates, with significant performance expected in Q3 and the second half of the year, suggesting a focus on companies with improving quarter-over-quarter and year-over-year results, as well as those poised for accelerated growth in 2026 [1][2][6] - High-value consumables and equipment performed relatively well in the first half of the year, with upstream medical device companies like Meihao Medical, Yingke Medical, and Haitai Xinguang showing high growth trends in Q3 [1][3][4] Key Trends and Insights - The strategy of expanding overseas is crucial for Chinese medical device companies to unlock a second growth curve, driven by domestic policy pressures and increased competition from local manufacturers [1][5] - The medical device sector is expected to see a significant improvement in Q3, with companies like Union Medical and Mindray anticipated to show performance turning points [4][8] - The high consumables segment is expected to see further improvement in Q3, benefiting from reduced impact from centralized procurement and the launch of new products, with companies like Huatai and Maipu Chunli Medical projected to achieve high growth [9] Investment Opportunities - Companies with high growth potential or rapid profit growth, such as Meihao Medical and those in the brain-computer interface and humanoid robot supply chains, are recommended for long-term holding [6][7] - Low-valuation companies expected to accelerate growth in 2026 include Meihao Medical, MicroPort Medical, and Yiyuan Technology, among others [12] - The IVD sector is facing challenges but is expected to see improvements in domestic growth rates, while overseas markets maintain high growth [10] Performance of Specific Companies - The Hong Kong medical device sector has shown significant innovation, with companies like Silan Tongqiang and MicroPort Medical demonstrating strong recovery in profitability [14] - The consumption medical services sector, led by Aier Eye Hospital, is outperforming serious medical services, with a notable increase in average transaction prices for procedures [16][17] Valuation and Market Position - The overall valuation of the medical services sector is at historically low levels, with the current PE ratio around the 20% percentile of the past five years [18] - Comprehensive hospitals are facing revenue declines due to healthcare payment reforms, with many experiencing over a 10% drop in income in the first half of 2025 [19][20] Recommendations for Future Monitoring - Long-term investment opportunities exist in both the Hong Kong and A-share medical device sectors, particularly in companies with strong innovation capabilities and international expansion potential [15] - Companies like Aier Eye Hospital and Hai Jiaya Medical are recommended for their leadership in their respective segments, while Yiyuan Medical is noted for its rapid overseas growth and strong cash flow [21][22]

《关于推动脑机接口产业创新发展的实施意见》的落地实施，为康复医疗赛道注入技术突破新动能。在 此机遇下，深耕康复领域20余年的翔宇医疗，正以脑机接口为核心，推动康复医疗从被动治疗向主动康 复跨越。 近日，翔宇医疗董事长、总经理、技术总监何永正接受上海证券报记者专访，详解公司"无创理念"的实 践、脑机接口技术的产业化进展，以及对康复医疗万亿级蓝海市场的布局与展望。 锚定康复赛道：以"无创理念"守护患者健康 2002年，何永正带领团队成立翔宇医疗，选择了在当年还非常"冷门"的康复赛道。"患者只要做手术， 就会对血管、神经、皮肤组织、骨骼造成损伤。我们希望用非手术、非药物的疗法给患者的健康保驾护 航。"何永正表示。 基于这样的"无创理念"，翔宇医疗开始了康复器械领域的探索。 目前，翔宇医疗已成为国内康复医疗器械行业中，少数能够提供康复医疗器械产品、一体化临床康复解 决方案及专业技术支持服务的综合型企业，构建了覆盖康复理疗、康复训练、康复护理等10大门类、55 大系列、上千种产品的全产业链布局，在康复医疗器械领域拥有相对完整的产品体系。 之所以成为康复器械领域的"全能型选手"，离不开翔宇医疗团队的深入调研和"搭建专班" ...

Market Overview - A-share market showed a fluctuating and differentiated trend, with major indices mostly declining while the Sci-Tech 50 Index rose against the trend, indicating resilience in the technology growth sector [1][2] - The Hong Kong stock market continued its upward trend, with the Hang Seng Technology Index slightly rising, driven by active performances in sectors like brain-computer interfaces and biotechnology [1][2] Index Performance - A-share indices experienced notable fluctuations, with the Shanghai Composite Index closing at 3856.45 points, down 0.1%, and the Shenzhen Component Index down 0.26% at 12971.8 points; the ChiNext Index fell 0.32% to 3056.3 points, influenced by the new energy industry chain [2] - The Sci-Tech 50 Index surged 1.52% to 1360.78 points, driven by hard technology sectors such as AI chips and computing infrastructure [2] - In the Hong Kong market, the Hang Seng Index rose 0.07% to 26465.87 points, while the Hang Seng Technology Index increased by 0.39% to 6067.05 points, marking three consecutive days of gains [2] Sector Highlights and Driving Logic - The A-share market exhibited a structural characteristic of "technology leading and consumption recovering," with policy-sensitive sectors and industrial transformation aligning [3] - The retail sector led gains, with the Wande Retail Index rising 1.36%, boosted by positive developments in U.S.-China trade talks regarding TikTok [3] - The electronics and computer sectors saw significant gains, with the GPU concept maintaining strength and the logic of domestic substitution for AI chips being reinforced [3] - In the Hong Kong market, technology growth and medical innovation drove performance, with brain-computer interface concepts experiencing a surge following product certifications [3] Underperforming Sectors and Driving Logic - A-share resource cyclical stocks and previously popular sectors collectively retreated, negatively impacting market sentiment; the non-ferrous metals sector fell 2.28% [4] - The lithium battery industry chain weakened for two consecutive days due to intensified competition and rising raw material costs [4] - In the Hong Kong market, cyclical and consumer sectors showed mixed performance, with the materials index dropping 2.96% due to industrial metal price corrections [4] Investment Strategy Recommendations - The current market is at a convergence of an "event vacuum period" and a "policy observation period," with cautious sentiment prevailing ahead of the Federal Reserve's meeting [5] - For A-shares, a focus on "technology independence and consumption recovery" is recommended, particularly in AI computing infrastructure and semiconductor equipment [6] - In the Hong Kong market, structural opportunities in "technology growth and medical innovation" should be seized, with attention on AI applications and core technology barriers [6]

齐鲁晚报·齐鲁壹点 记者 张志恒 尹睿 在科技飞速发展的当下，具身智能机器人与脑机接口技术正成为人工智能领域的热门方向，它们不仅承载着改变生产生活方式的期待，也面临着从实验室走 向商用的诸多挑战。近日，围绕相关话题，记者专访了山东中科先进技术有限公司总经理、山东省机器人研究会副会长李卫民，深入探讨其应用场景、核心 优势、研发难点及未来前景。 具身智能机器人：从 "跳舞表演"到 "车间帮手"，汽车制造与家庭服务成关键赛道 谈及具身智能机器人的应用场景，李卫民首先指出了其"终极目标"—— 汽车制造领域。"汽车总装生产线目前仍依赖大量人工，若具身智能机器人能在此领 域取代人工，意味着其智能水平已达到较高层次。"他表示，当前多家人形机器人企业均将目标锁定与整车厂合作，推动机器人落地生产线，这也是行业公 认的典型应用场景。 对于未来5年的发展，李卫民持乐观态度。他预测，随着技术迭代，具身智能机器人将逐步普及，且支持"在线升级"—— 企业开发的新功能可直接推送至已 售出的机器人，推动整体智能化水平提升。同时，人形机器人企业将逐步开放更多接口，允许用户在硬件平台上进行二次开发，就像工业机器人时代那样， 实现"基础功能+个性 ...

Group 1: Policy and Market Reforms - The State Council of China has approved a pilot program for market-oriented allocation of factors in 10 regions, including major urban areas and economic zones, to be implemented over the next two years [1] - The National Development and Reform Commission will work with pilot regions to organize and implement the reform, aiming to create a replicable model for nationwide application [1] Group 2: Stock Market Performance - A-shares experienced a significant rally, with the Shanghai Composite Index rising over 1%, the Shenzhen Component Index increasing over 3%, and the ChiNext Index surging over 5% [2] - The margin trading balance reached a historical high of 23,255.93 billion yuan, with an increase of over 63 billion yuan in September alone [2] - Analysts believe that the A-share market has sustainable upward momentum supported by favorable policy expectations and stable liquidity [2] Group 3: Insurance Industry Developments - Leading insurance companies have reported profitability in their new energy vehicle insurance segments, marking a turnaround from previous losses [3] - Factors contributing to this profitability include improved data accumulation for pricing, increased premium scale, and enhanced collaboration with automakers [3] - The new energy vehicle insurance sector is expected to reach a turning point in profitability within the next three years [3] Group 4: Investment Strategies - Multiple public fund companies are optimistic about equity asset investment opportunities, indicating a favorable market environment for structural opportunities [4] - The trend of long-term capital entering the market is accelerating, with significant growth in stock allocations by insurance companies and the total scale of domestic ETFs surpassing 50 trillion yuan [8] - The "insurance buying insurance" trend is emerging, with companies like Ping An increasing their stakes in other insurance firms, reflecting a positive outlook on the industry [9] Group 5: Technology and Innovation - The semiconductor industry is witnessing a significant acquisition, with Chipone Technology being acquired by Xinyu Semiconductor to enhance its RISC-V CPU IP capabilities [5] - The brain-computer interface industry is expected to accelerate its development, with several A-share companies reporting progress and new product launches [6][7] - Solid-state batteries are gaining traction in the market, seen as a key technology for global energy transition, with A-share related stocks performing strongly [12] Group 6: Mergers and Acquisitions - Dongyangguang Group has completed a major acquisition of Qinhuai Data's China operations for 28 billion yuan, marking a significant milestone in the data center industry [13] - This acquisition is indicative of a deeper capital integration phase within the data center sector, leading to increased industry concentration and a focus on location value and customer loyalty [14]

Core Insights - The domestic brain-computer interface (BCI) industry is entering a phase of accelerated development in 2025, with significant advancements emerging continuously [1] - Multiple A-share listed companies have disclosed recent updates on their BCI businesses, indicating a clear industry application blueprint and a push towards commercialization [2][5] Company Developments - MaiLand has focused on non-invasive BCIs, achieving technological accumulation in areas such as upper limb and hand movement robotics and non-invasive neural regulation, with clinical validation underway for key projects [2][7] - Xiangyu Medical has launched over 10 new products, including BCIs and exoskeleton robots, and has established a collaborative center for BCI rehabilitation treatment and neural regulation [3][7] - QiSheng Technology is exploring cross-industry integration with BCI technology, particularly in sleep health, and has set up a digital sleep industry fund [3] - Zhongke Information has established a laboratory for cognitive and smart medical applications, focusing on developing closed-loop BCI systems for intelligent anesthesia and rehabilitation [3][7] - Aipeng Medical is working on monitoring brain states during surgery and developing treatment systems for conditions like insomnia and ADHD [3][7] Industry Trends - The BCI industry is seeing a multi-faceted approach to commercialization, with companies accelerating investment and product rollout, supported by local policies that facilitate the commercialization process [5][6] - The Shanghai Medical Insurance Bureau has introduced new medical service pricing items for invasive and non-invasive BCI procedures, which is expected to clear obstacles for commercialization [6] - Companies like Daoshi Technology and Botuo Bio are making strategic investments in BCI-related ventures, indicating a growing interest in the sector [5][6]